Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples

BACKGROUND: Monitoring hemophilia treatment with extended half‐life products is challenging for coagulation laboratories since factor assays may show substantial differences between results obtained with the one‐stage assay (OSA) and the chromogenic substrate assay (CSA). OBJECTIVES: The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Augustsson, Cecilia, Norström, Eva, Andersson, Nadine Gretenkort, Zetterberg, Eva, Astermark, Jan, Strandberg, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles ‐ Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590307/
https://www.ncbi.nlm.nih.gov/pubmed/33134777
http://dx.doi.org/10.1002/rth2.12421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590307/
https://www.ncbi.nlm.nih.gov/pubmed/33134777
http://dx.doi.org/10.1002/rth2.12421

Ejemplares similares